# A Study of DS-1471a In Subjects With Advanced Solid Tumors

> **NCT06074705** · PHASE1 · TERMINATED · sponsor: **Daiichi Sankyo Co., Ltd.** · enrollment: 17 (actual)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** DS-1471a

## Key facts

- **NCT ID:** NCT06074705
- **Lead sponsor:** Daiichi Sankyo Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-08-04
- **Primary completion:** 2025-07-29
- **Final completion:** 2025-07-29
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** The study was terminated by the sponsor due to a business decision.
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06074705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06074705, "A Study of DS-1471a In Subjects With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06074705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*